What happened
TKG Huchems updated the disclosed terms of an acquisition of AprilBio, now worth US$102M.
For context, this deal is worth about 12.8% of the company's own total assets.
| Target | AprilBio |
|---|---|
| Deal value | US$102M |
| vs. company assets | 12.8% |
| Filed | 2026-07-23, [Amended] Decision to acquire shares/equity in another company |
| Source | DART rcept 20260723800708 → open original filing |
Source: DART. Information only, not investment advice.